This is the first time the mechanism for PGC1β‐mediated LDHA expression in multiple myeloma has been identified, and this provides us with a novel antitumor strategy through targeting of the PGC1β/LDHA axis. This evidence concerns the gene PPARGC1B and plasma cell myeloma.